Comparison of Preoperative Frailty Assessment Tools

NCT ID: NCT06889545

Last Updated: 2025-04-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

584 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-04-15

Study Completion Date

2027-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Frailty is a significant risk factor for postoperative complications and functional decline. Preoperative assessment of frailty is therefore recommended in all older adults. However, despite the availability of many frailty tools, few have been tested in the preoperative setting and there is little comparison of their predictive value in identifying patients at risk. The aim of this study is to investigate which of the following instruments for determining frailty has the highest predictive power with regard to the occurrence of postoperative complications: Risk Analysis Index, Clinical Frailty Scale, the Groningen Frailty Indicator, the Edmonton Frail Scale and the LUCAS-FI. The aim of this research project is to identify a suitable frailty instrument for preoperative risk stratification of older patients during the premedication visit.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Frailty Frailty in Older Adults Frailty/Sarcopenia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Older patients

Patients at 70 years and above scheduled for surgery

Assessment of frailty using multiple tools

Intervention Type OTHER

This is an observational study without any intervention. Frailty is assessed using multiple tools and postoperative outcome is compared.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Assessment of frailty using multiple tools

This is an observational study without any intervention. Frailty is assessed using multiple tools and postoperative outcome is compared.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 70 years and older
* scheduled surgery
* estimated time of surgery 120 Minutes or more

Exclusion Criteria

* insufficient German language skills (for cognitive testing)
* mental retardation
* relevant psychiatric disorder (not allowing for cognitive testing)
Minimum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universitätsklinikum Hamburg-Eppendorf

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dr. Cynthia Olotu, MD

Role: PRINCIPAL_INVESTIGATOR

University Medical Centre Hamburg

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Medical Centre Hamburg

Hamburg, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Dr. Cynthia Olotu, MD

Role: CONTACT

0049 40 7410 52415

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Dr. Silke Schrum

Role: primary

0049 40 7410 54290

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-101410-BO-ff

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.